Regeneron Pharmaceuticals
REGN
#288
Rank
โ‚น6.844 T
Marketcap
โ‚น64,578
Share price
-0.61%
Change (1 day)
-2.79%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - P/B ratio

P/B ratio as of December 2025 : 2.46

According to Regeneron Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 5.34378.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Regeneron Pharmaceuticals - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-31N/A-100%
2024-12-312.67-27.61%
2023-12-313.686.27%
2022-12-313.47-4.19%
2021-12-313.62-22.61%
2020-12-314.6825.23%
2019-12-313.73-19.69%
2018-12-314.65-29.28%
2017-12-316.57-24.45%
2016-12-318.70-44.02%
2015-12-3115.5-5.67%
2014-12-3116.517.23%
2013-12-3114.15.17%
2012-12-3113.426.5%
2011-12-3110.689.94%
2010-12-315.5612.52%
2009-12-314.9442.48%
2008-12-313.47-16.15%
2007-12-314.14-31.72%
2006-12-316.06-23.02%
2005-12-317.87179.3%
2004-12-312.82-52.54%
2003-12-315.945.23%
2002-12-315.64

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Amgen
AMGN
18.5 650.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
259 10,421.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
1.46-40.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
6.14 149.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
5.67 130.40%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
1.40-43.04%๐Ÿ‡ซ๐Ÿ‡ท France